Main Title |
Evaluation of the potential carcinogenicity of DDE (72-55-9) / |
CORP Author |
Syracuse Research Corp., NY. ;Environmental Monitoring and Services, Inc., Washington, DC.;Environmental Protection Agency, Washington, DC. Office of Health and Environmental Assessment. |
Publisher |
U.S. Environmental Protection Agency, Office of Emergency and Remedial Response ; |
Year Published |
1988 |
Report Number |
EPA/600/8-91/100; EPA-68-03-3112; EPA-68-03-3182; OHEA-C-073-074 |
Stock Number |
PB93-185247 |
Subjects |
Aromatic compounds--Carcinogenicity ;
Chlornapazine--Carcinogenicity
|
Additional Subjects |
DDE insecticide ;
Toxicity ;
Risk assessment ;
Public health ;
Exposure ;
Neoplasms ;
Hazardous materials ;
Tolerances(Physiology) ;
Carcinogenicity ;
Dose-response relationships ;
CAS Registry No: 72-55-9
|
Internet Access |
|
Holdings |
Library |
Call Number |
Additional Info |
Location |
Last Modified |
Checkout Status |
NTIS |
PB93-185247 |
Some EPA libraries have a fiche copy filed under the call number shown. |
|
07/26/2022 |
|
Collation |
21 pages ; 28 cm |
Abstract |
DDE is a probable human carcinogen, classified as weight-of-evidence Group B2 under the EPA Guidelines for Carcinogen Risk Assessment. Evidence on potential carcinogenicity from animal studies is 'Sufficient,' and the evidence from human studies is 'Inadequate.' The potency factor (F) for DDE is estimated to be 3.82 (mg/kg/day)(-1), placing it in potency group 2 according to the CAG's methodology for evaluating potential carcinogens. Combining the weight-of-evidence group and the potency group, DDE is assigned a 'MEDIUM' hazard ranking. |
Notes |
Cover title. "June 1988." Includes bibliographical references. Microfiche. |